Minireview: nuclear receptor and coregulator proteomics--2012 and beyond
- PMID: 22745194
- PMCID: PMC3458220
- DOI: 10.1210/me.2012-1114
Minireview: nuclear receptor and coregulator proteomics--2012 and beyond
Abstract
The focus of our decade-long National Institutes of Health-sponsored NURSA Proteomics Atlas was to catalog and understand the composition of the steady-state interactome for all nuclear receptor coregulator complexes in a human cell. In this Perspective, we present a summary of the proteomics of coregulator complexes with examples of how one might use the NURSA data for future exploitation. The application of this information to the identification of the coregulator proteins that contribute to the molecular basis of polygenic diseases is emphasized.
Figures

Similar articles
-
Increased interaction between DJ-1 and the Mi-2/ nucleosome remodelling and deacetylase complex during cellular stress.Proteomics. 2010 Apr;10(7):1494-504. doi: 10.1002/pmic.200900586. Proteomics. 2010. PMID: 20127688
-
Dissecting the molecular mechanism of nuclear receptor action: transcription coactivators and corepressors.Exp Mol Med. 2000 Jun 30;32(2):53-60. doi: 10.1038/emm.2000.10. Exp Mol Med. 2000. PMID: 10926115 Review. No abstract available.
-
Nuclear receptor coregulators and human disease.Endocr Rev. 2007 Aug;28(5):575-87. doi: 10.1210/er.2007-0012. Epub 2007 Jul 3. Endocr Rev. 2007. PMID: 17609497 Review.
-
ETO interacting proteins.Oncogene. 2004 May 24;23(24):4270-4. doi: 10.1038/sj.onc.1207674. Oncogene. 2004. PMID: 15156183 Review.
-
Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants.Mol Cell Biol. 2002 Oct;22(19):6831-41. doi: 10.1128/MCB.22.19.6831-6841.2002. Mol Cell Biol. 2002. PMID: 12215540 Free PMC article.
Cited by
-
The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice.Int J Mol Sci. 2023 Feb 21;24(5):4298. doi: 10.3390/ijms24054298. Int J Mol Sci. 2023. PMID: 36901727 Free PMC article.
-
Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.Mol Cell Biochem. 2020 Jan;464(1-2):153-167. doi: 10.1007/s11010-019-03657-x. Epub 2019 Nov 27. Mol Cell Biochem. 2020. PMID: 31773467
-
The role of genetics in estrogen responses: a critical piece of an intricate puzzle.FASEB J. 2014 Dec;28(12):5042-54. doi: 10.1096/fj.14-260307. Epub 2014 Sep 11. FASEB J. 2014. PMID: 25212221 Free PMC article. Review.
-
The Progestin Receptor Interactome in the Female Mouse Hypothalamus: Interactions with Synaptic Proteins Are Isoform Specific and Ligand Dependent.eNeuro. 2017 Sep 20;4(5):ENEURO.0272-17.2017. doi: 10.1523/ENEURO.0272-17.2017. eCollection 2017 Sep-Oct. eNeuro. 2017. PMID: 28955722 Free PMC article.
-
ELF3 is a repressor of androgen receptor action in prostate cancer cells.Oncogene. 2014 Feb 13;33(7):862-71. doi: 10.1038/onc.2013.15. Epub 2013 Feb 25. Oncogene. 2014. PMID: 23435425 Free PMC article.
References
-
- Vegeto E, Allan GF, Schrader WT, Tsai MJ, McDonnell DP, O'Malley BW. 1992. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69:703–713 - PubMed
-
- Oñate SA, Tsai SY, Tsai MJ, O'Malley BW. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354–1357 - PubMed
-
- Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW. 1998. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922–1925 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous